Structure and Function of Telomerase
端粒酶的结构和功能
基本信息
- 批准号:7933115
- 负责人:
- 金额:$ 17.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2010-09-30
- 项目状态:已结题
- 来源:
- 关键词:Affinity ChromatographyAnimal ModelBiochemicalBiologicalBiological AssayBiological ModelsCaspase-1Cell divisionCellsChromosomesChromosomes, Human, Pair 3ComplexCrystallographyDNA biosynthesisDNA-Directed DNA PolymeraseDiseaseEnzymesEpitopesEukaryotic CellFluorescence Resonance Energy TransferFundingGeneticGenomeGoalsHealthHoloenzymesHumanIn VitroKnowledgeLaboratoriesMalignant NeoplasmsMethodsMolecularMolecular GeneticsProcessPropertyProteinsProtozoaRNA-Directed DNA PolymeraseRegulationRibonucleoproteinsRoleShort Tandem RepeatSiteSomatic CellStagingStructural ProteinStructureTelomeraseTelomerase InhibitorTelomerase RNA ComponentTelomere Length MaintenanceTetrahymenaTetrahymena thermophilaTherapeuticcancer cellcrosslinkenzyme mechanismenzyme structuregenetic manipulationin vivoinsightnovelp65prematurerecombinant RNAreconstitutiontelomerase reverse transcriptasetelomeretranscriptional coactivator p75
项目摘要
The telomerase ribonucleoprotein reverse transcriptase adds telomeric repeats to chromosome ends. This
unusual mode of DMAsynthesis counteracts the terminal sequence loss that occurs upon genome
replication by DNA-templated DNA polymerases. Most eukaryotic cells have few chromosomes, few
telomeres and little telomerase. Ciliated protozoa are the exception: they possess thousands to millions of
telomeres per cell and high levels of telomerase. This proposal capitalizes on advantages of the ciliate
Tetrahymena thermophila for studies of telomerase. Telomerase abundance facilitates direct biochemical
assays of endogenously assembled enzyme. Studies of Tetrahymena telomerase are also aided by
unparalleled in vitro reconstitution assays and robust methods for molecular genetic manipulation in vivo.
Endogenously assembled Tetrahymena and human telomerases show remarkably similar biochemical
properties, particularly when compared to telomerases from other model organisms. Thus, studies of
Tetrahymena telomerase will continue to inform studies of the less experimentally tractable human enzyme.
Our understanding of telomerase is limited by scant knowledge of enzyme structure and by the difficulty of
identifying and characterizing factors required for endogenous enzyme function. Filling these knowledge
gaps is the long-term goal of this proposal. Following from our previous in vitro reconstitution studies, Aim I
describes recombinant RNA and protein structural studies using site-specific cross-linking, fluorescence
resonance energy transfer and crystallography. Following from our previous affinity purification of an
endogenously assembled telomerase holoenzyme, Aims II, III and IV use in vitro and in vivo reconstitution
assays to characterize the biochemical and biological activities of four new holoenzyme proteins.
Insights about telomerase structure and function have direct relevance for the improvement of human
health. Most human somatic cells lack functional telomerase and therefore have a capacity for division that is
limited by telomere erosion. In diseases characterized by premature telomere loss, temporary telomerase
activation could restore cellular renewal potential. Cancer cells aberrantly activate telomerase to gain
extended cell division capacity and require telomerase for their continued viability. For this reason,
telomerase inhibitors could be broadly effective cancer therapeutics.
端粒酶核糖核蛋白逆转录酶将端粒重复序列添加到染色体末端。这
一种不寻常的DMA合成方式抵消了基因组末端序列的丢失
DNA模板DNA聚合酶复制。大多数真核细胞的染色体很少,
端粒和少量的端粒酶。有纤毛的原生动物是个例外:它们拥有数千到数百万的
每个细胞的端粒和高水平的端粒酶。这个建议利用了纤毛虫的优势
嗜热四膜虫用于端粒酶的研究。端粒酶丰度促进直接生化
内源性组装酶的测定。四膜虫端粒酶的研究也有助于
无与伦比的体外重建测定和体内分子遗传操作的稳健方法。
内源性组装的四膜虫和人类端粒酶显示出非常相似的生化特性,
这些特性,特别是当与来自其他模式生物的端粒酶相比时。因此,研究
四膜虫端粒酶将继续为研究这种在实验上不易处理的人类酶提供信息。
我们对端粒酶的理解受到酶结构知识的限制,
鉴定和表征内源酶功能所需的因素。把这些知识
消除差距是本提案的长期目标。根据我们之前的体外重建研究,Aim I
描述了重组RNA和蛋白质结构的研究,使用位点特异性交联,荧光
共振能量转移和晶体学。从我们先前的亲和纯化一种
内源性组装的端粒酶全酶,目的II、III和IV用于体外和体内重建
分析,以表征四种新的全酶蛋白的生物化学和生物活性。
对端粒酶结构和功能的了解对于改善人类的生物学行为具有直接的意义。
健康大多数人类体细胞缺乏功能性端粒酶,因此具有分裂能力,
受到端粒侵蚀的限制在以端粒过早丢失为特征的疾病中,
激活可以恢复细胞更新潜力。癌细胞异常激活端粒酶,
延长的细胞分裂能力,并且需要端粒酶来维持它们的持续活力。基于这个理由,
端粒酶抑制剂可能是广泛有效的癌症治疗剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kathleen Collins其他文献
Kathleen Collins的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kathleen Collins', 18)}}的其他基金
Human genetic supplementation without donor DNA or a DNA break
无需供体 DNA 或 DNA 断裂的人类基因补充
- 批准号:
10532612 - 财政年份:2022
- 资助金额:
$ 17.14万 - 项目类别:
Human genetic supplementation without donor DNA or a DNA break
无需供体 DNA 或 DNA 断裂的人类基因补充
- 批准号:
10471949 - 财政年份:2020
- 资助金额:
$ 17.14万 - 项目类别:
Human genetic supplementation without donor DNA or a DNA break
无需供体 DNA 或 DNA 断裂的人类基因补充
- 批准号:
10687195 - 财政年份:2020
- 资助金额:
$ 17.14万 - 项目类别:
Human genetic supplementation without donor DNA or a DNA break
无需供体 DNA 或 DNA 断裂的人类基因补充
- 批准号:
10912151 - 财政年份:2020
- 资助金额:
$ 17.14万 - 项目类别:
Human genetic supplementation without donor DNA or a DNA break
无需供体 DNA 或 DNA 断裂的人类基因补充
- 批准号:
10259688 - 财政年份:2020
- 资助金额:
$ 17.14万 - 项目类别:
Human genetic supplementation without donor DNA or a DNA break
无需供体 DNA 或 DNA 断裂的人类基因补充
- 批准号:
10683044 - 财政年份:2020
- 资助金额:
$ 17.14万 - 项目类别:
Human genetic supplementation without donor DNA or a DNA break
无需供体 DNA 或 DNA 断裂的人类基因补充
- 批准号:
10012227 - 财政年份:2020
- 资助金额:
$ 17.14万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 17.14万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 17.14万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 17.14万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 17.14万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 17.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 17.14万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 17.14万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 17.14万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 17.14万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 17.14万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




